David S Burgess

9PUBLICATIONS
12CO-AUTHORS
ClinimetricsMedical infection agents (incl. prions)Infectious diseasesMedical bacteriologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Comparison of Bayesian and First-Order Estimations of Vancomycin Area Under the Curve in Pediatrics Using One- and Two-Concentration Methods.

|May 20, 2025
Optimizing cefazolin dosing for central nervous system infections: insights from population pharmacokinetics and Monte Carlo simulations.

C Tyler Pitcock, David S Burgess, Katie B Olney

|Oct 28, 2024
The effect of carbapenem-resistant versus carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center.

Justin A Clark, David S Burgess, Daniela C Moga

|Aug 20, 2024
Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides against VIM-producing Enterobacteriaceae.

Justin A Clark, David S Burgess

|Jul 30, 2024
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections.

Katie B Olney, Manjunath P Pai, Jenni K Thomas

|Mar 27, 2024
Vancomycin AUC0-24 estimation using first-order pharmacokinetic methods in pediatric patients.

Hope H Brandon, David S Burgess, Katie L Wallace

Pageof 2

Frequent Collaborators

6 joint publications

Katie B Olney

3 joint publications

Justin A Clark

2 joint publications

Alexander H Flannery

1 joint publications

Aaron M Cook